These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 4729555)

  • 81. A comparison of expiration dating period estimation methods.
    Rahman MA
    J Biopharm Stat; 1992; 2(1):69-82. PubMed ID: 1300206
    [TBL] [Abstract][Full Text] [Related]  

  • 82. 2012 drug packaging review: many dangerous, reportable flaws.
    Prescrire Int; 2013 May; 22(138):134-7. PubMed ID: 23819184
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inadequate ampoule labelling.
    Adekanye O; Vasoya R
    Anaesthesia; 2006 Aug; 61(8):819; author reply 819. PubMed ID: 16867118
    [No Abstract]   [Full Text] [Related]  

  • 84. [Production and control in pharmaceutic industry. Claims and principles in production of sterile preparations. Production in bigger plants].
    Schnorf U
    Pharm Acta Helv; 1973 Feb; 48(2):83-100. PubMed ID: 4706311
    [No Abstract]   [Full Text] [Related]  

  • 85. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule.
    Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Anticounterfeit protection of pharmaceutical products with spatial mapping of X-ray-detectable barcodes and logos.
    Musumeci D; Hu C; Ward MD
    Anal Chem; 2011 Oct; 83(19):7444-50. PubMed ID: 21877684
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Anticipated revisions to the current good manufacturing practice regulations.
    Mitchell CM
    Bull Parenter Drug Assoc; 1974; 28(3):146-51. PubMed ID: 4845938
    [No Abstract]   [Full Text] [Related]  

  • 88. [Control on an injectables production line. I. Control of microporosity].
    Lencioni E; Franchi G; Corti P; Panzarasa L
    Boll Chim Farm; 1986 Jan; 125(1):3-6. PubMed ID: 3730175
    [No Abstract]   [Full Text] [Related]  

  • 89. Drug safety: the viewpoint of the pharmaceutical manufacturing industry.
    Wigle WW
    Can Med Assoc J; 1968 Feb; 98(6):314-7. PubMed ID: 5636099
    [No Abstract]   [Full Text] [Related]  

  • 90. ASHP technical assistance bulletin on compounding nonsterile products in pharmacies. American Society of Hospital Pharmacists.
    Am J Hosp Pharm; 1994 Jun; 51(11):1441-8. PubMed ID: 7942879
    [No Abstract]   [Full Text] [Related]  

  • 91. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

  • 92. The Coronary Drug Project. Role and methods of the Drug Procurement and Distribution Center.
    Brennan EC
    Control Clin Trials; 1983 Dec; 4(4):409-17. PubMed ID: 6675892
    [No Abstract]   [Full Text] [Related]  

  • 93. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 3. Oral Drug Products.
    Allain L; Baertschi SW; Clapham D; Foti C; Lantaff WM; Reed RA; Templeton AC; Tønnesen HH
    J Pharm Sci; 2016 May; 105(5):1586-1594. PubMed ID: 27056630
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Quality control of radiopharmaceuticals.
    Pfeiffer G
    Nuklearmedizin; 1984 Feb; 23(1):4-8. PubMed ID: 6728692
    [TBL] [Abstract][Full Text] [Related]  

  • 95. USP standards and activities affecting pharmacy practice.
    Okeke CC; Barletta FP; Gray VA; Krasowski JA; Paul WL; Belson JJ; Grady LT
    Am J Health Syst Pharm; 1997 Jul; 54(14):1633-8. PubMed ID: 9248610
    [No Abstract]   [Full Text] [Related]  

  • 96. [Various standards of security and hygiene in the storage and handling of cyanides and hydrocyanides. Medical treatment in case of poisoning].
    Saez de Jauregui y Mendaza PM
    Rev Sanid Hig Publica (Madr); 1973 Jun; 47(6):579-87. PubMed ID: 4366927
    [No Abstract]   [Full Text] [Related]  

  • 97. [Proposals for the legal control of the testing and introduction of drugs based on a comparison of drug laws in other countries].
    Burow W; Lüllmann H
    Schriftenr Geb Off Gesundheitswes; 1971; 31():1-64. PubMed ID: 5153578
    [No Abstract]   [Full Text] [Related]  

  • 98. Checking the anaesthetic machine, drugs, and monitoring devices.
    Crosby WM
    Anaesth Intensive Care; 1988 Feb; 16(1):32-5. PubMed ID: 3364688
    [No Abstract]   [Full Text] [Related]  

  • 99. [Permeability of some drugs through polyethylene of high pressure and polypropylene].
    Artem'ev AI
    Aptechn Delo; 1966; 15(6):29-34. PubMed ID: 6001302
    [No Abstract]   [Full Text] [Related]  

  • 100. The work of the National Patient Safety Agency to improve medication safety.
    Cousins DH; Baker M
    Br J Gen Pract; 2004 May; 54(502):331-3. PubMed ID: 15113513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.